Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Beroni Group Ord Shs BNIGF

Healthcare Biotechnology
Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is engaged in the commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. It is engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based... see more

Recent & Breaking News (OTCQB:BNIGF)

Beroni Group's Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

GlobeNewswire June 1, 2022

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

GlobeNewswire March 31, 2022

Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT

GlobeNewswire March 23, 2022

Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China

GlobeNewswire January 31, 2022

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

GlobeNewswire November 18, 2021

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

GlobeNewswire October 28, 2021

Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO

GlobeNewswire September 9, 2021

Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)

GlobeNewswire August 31, 2021

Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

GlobeNewswire August 18, 2021

Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans

GlobeNewswire May 28, 2021

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

GlobeNewswire May 28, 2021

Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

GlobeNewswire April 27, 2021

Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company

GlobeNewswire February 3, 2021

Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

GlobeNewswire December 21, 2020

Beroni Group Launches a New Probiotics Health Product in China

GlobeNewswire November 10, 2020

Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

GlobeNewswire November 9, 2020

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

GlobeNewswire October 19, 2020

Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan

GlobeNewswire September 8, 2020

Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

GlobeNewswire August 12, 2020

Beroni Group Has Successfully Constructed and Purified 24 Types of Nanobodies for Detection and Treatment of COVID-19

GlobeNewswire August 4, 2020
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested